Free serum IgE suppression with omalizumab and clinical outcomes in asthma

被引：0
|
作者：
Liu, Chuntao [1 ]
Li, Jing [2 ]
Yang, Jing [3 ]
Wang, Lu [3 ]
Humphries, Michael [3 ]
Kottakis, Ioannis Ioannis [4 ]
Fogel, Robert [5 ]
Lau, Xiao Hoong [6 ]
Zhong, Nanshan [2 ]
机构：
[1] Sichuan Univ, Dept Resp Dis, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Beijing Novartis Pharma Co Ltd, Beijing, Peoples R China
[4] Novartis Pharma AG, Basel, Switzerland
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Novartis Business Serv PLS, Petaling Jaya, Malaysia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; Biomarkers; Allergy;
D O I：
10.1183/13993003.congress-2019.PA2545
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2545
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Monitoring free serum IgE in severe asthma patients treated with omalizumab
    Korn, Stephanie
    Haasler, Ina
    Fliedner, Florian
    Becher, Gunther
    Strohner, Pavel
    Staatz, Antonia
    Taube, Christian
    Buhl, Roland
    RESPIRATORY MEDICINE, 2012, 106 (11) : 1494 - 1500
  • [2] Free serum IgE in patients with severe allergic asthma treated with omalizumab
    Korn, S.
    Haasler, I.
    Jung, M.
    Strohner, P.
    Straatz, A.
    Schaefer, A.
    Becher, G.
    Taube, C.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [3] Monitoring Free Serum IgE In Severe Asthma Patients Treated With Omalizumab
    Korn, S.
    Haasler, I.
    Fliedner, F.
    Becher, G.
    Strohner, P.
    Staatz, A.
    Taube, C.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [4] Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
    Tajiri, T.
    Matsumoto, H.
    Gon, Y.
    Ito, R.
    Hashimoto, S.
    Izuhara, K.
    Suzukawa, M.
    Ohta, K.
    Ono, J.
    Ohta, S.
    Ito, I.
    Oguma, T.
    Inoue, H.
    Iwata, T.
    Kanemitsu, Y.
    Nagasaki, T.
    Niimi, A.
    Mishima, M.
    ALLERGY, 2016, 71 (10) : 1472 - 1479
  • [5] Utility Of Serum Periostin And Free Ige Levels In Evaluating Responsiveness To Omalizumab In Patients With Severe Asthma
    Tajiri, T.
    Matsumoto, H.
    Gon, Y.
    Ito, R.
    Hashimoto, S.
    Izuhara, K.
    Suzukawa, M.
    Ohta, K.
    Ono, J.
    Ohta, S.
    Ito, I.
    Oguma, T.
    Inoue, H.
    Iwata, T.
    Nagasaki, T.
    Kanemitsu, Y.
    Niimi, A.
    Mishima, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] OMALIZUMAB RESPONSE IN A PATIENT WITH LOW SERUM IGE AND SEVERE ASTHMA
    Patel, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S69 - S69
  • [7] MEASUREMENT OF SERUM FREE IGE IN THE PATIENTS TREATED WITH OMALIZUMAB
    Ito, Reiko
    Gon, Yasuhiro
    Kogawa, Noriko
    Sekiyama, Tadataka
    Hiranuma, Hisato
    Hattori, Tomohiro
    Maruoka, Shuichiro
    Hashimoto, Shu
    RESPIROLOGY, 2013, 18 : 156 - 156
  • [8] Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma
    Gu, Chao
    Upchurch, Katherine
    Mamaril-Davis, James
    Wiest, Matthew
    Lanier, Bobby
    Millard, Mark
    Turner, Jacob
    Joo, HyeMee
    Oh, SangKon
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (10): : 1196 - 1199
  • [9] Total and free IgE in evolution of severe asthma after omalizumab treatment
    Vennera, Maria del Carmen
    Pascal, Mariona
    Nunez, Ebymar Arismendi
    Picado, Cesar
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] Omalizumab treatment is associated with improvement in outcomes in children with asthma despite pretreatment serum IgE exceeding dosing guidelines
    Atkinson, Claire
    Burbank, Allison
    Schworer, Stephen
    Hernandez, Michelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB17 - AB17
12345